The National Oesophago-Gastric Cancer Audit (NOGCA) was established to evaluate the quality of care received by patients with oesophago-gastric (OG) cancer in England and Wales.
It collects prospective data on adult patients diagnosed in England and Wales with invasive epithelial cancer of the oesophagus, gastro-oesophageal junction (GOJ) or stomach, and patients diagnosed with high grade dysplasia (HGD) of the oesophagus. This report describes the care received by patients diagnosed between April 2016 and March 2018 and their outcomes.
All 134 NHS acute trusts in England and the 6 local health boards in Wales participated in the 2016-18 audit period.
19.12.2019: Version 2 – We have re-issued the 2019 NOGCA Annual report (published on Friday 13 December) to correct some figures in the Executive Summary that relate to the care of patients with high grade dysplasia (pages 3 and 4) and some figures in the infographics (pages 7 and 8). We regret the original report contained these errors and apologise for any inconvenience this may have caused. The report conclusions and recommendations are unchanged and the figures in the main body of the report were correct.